45 related articles for article (PubMed ID: 20857409)
1. KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of merkel cell carcinoma in vitro.
Krasagakis K; Fragiadaki I; Metaxari M; Krüger-Krasagakis S; Tzanakakis GN; Stathopoulos EN; Eberle J; Tavernarakis N; Tosca AD
J Cell Physiol; 2011 Apr; 226(4):1099-109. PubMed ID: 20857409
[TBL] [Abstract][Full Text] [Related]
2. Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells.
Caliceti C; Zambonin L; Prata C; Vieceli Dalla Sega F; Hakim G; Hrelia S; Fiorentini D
PLoS One; 2012; 7(7):e41246. PubMed ID: 22859971
[TBL] [Abstract][Full Text] [Related]
3. Signaling of c-kit in dendritic cells influences adaptive immunity.
Ray P; Krishnamoorthy N; Oriss TB; Ray A
Ann N Y Acad Sci; 2010 Jan; 1183():104-22. PubMed ID: 20146711
[TBL] [Abstract][Full Text] [Related]
4. Expression of proto-oncogene KIT is up-regulated in subset of human meningiomas.
Saini M; Jha AN; Abrari A; Ali S
BMC Cancer; 2012 Jun; 12():212. PubMed ID: 22672386
[TBL] [Abstract][Full Text] [Related]
5. Structure of the active core of human stem cell factor and analysis of binding to its receptor kit.
Jiang X; Gurel O; Mendiaz EA; Stearns GW; Clogston CL; Lu HS; Osslund TD; Syed RS; Langley KE; Hendrickson WA
EMBO J; 2000 Jul; 19(13):3192-203. PubMed ID: 10880433
[TBL] [Abstract][Full Text] [Related]
6. KGF Promotes Paracrine Activation of the SCF/c-KIT Axis from Human Keratinocytes to Melanoma Cells.
Belleudi F; Cardinali G; Kovacs D; Picardo M; Torrisi MR
Transl Oncol; 2010 Apr; 3(2):80-90. PubMed ID: 20360932
[TBL] [Abstract][Full Text] [Related]
7. Merkel Cell Carcinoma-Update on Diagnosis, Management and Future Perspectives.
Zaggana E; Konstantinou MP; Krasagakis GH; de Bree E; Kalpakis K; Mavroudis D; Krasagakis K
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612102
[TBL] [Abstract][Full Text] [Related]
8. c-Kit Induces Migration of Triple-Negative Breast Cancer Cells and Is a Promising Target for Tyrosine Kinase Inhibitor Treatment.
López-Mejía JA; Tallabs-Utrilla LF; Salazar-Sojo P; Mantilla-Ollarves JC; Sánchez-Carballido MA; Rocha-Zavaleta L
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955836
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
Kefayat A; Amouheidari A; Ghahremani F; Alirezaei Z
Cancer Med; 2021 Aug; 10(15):5154-5162. PubMed ID: 34250760
[TBL] [Abstract][Full Text] [Related]
10. The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling.
Faria M; Shepherd P; Pan Y; Chatterjee SS; Navone N; Gustafsson JÅ; Strom A
Oncotarget; 2018 Nov; 9(91):36273-36288. PubMed ID: 30555629
[TBL] [Abstract][Full Text] [Related]
11. The biology and treatment of Merkel cell carcinoma: current understanding and research priorities.
Harms PW; Harms KL; Moore PS; DeCaprio JA; Nghiem P; Wong MKK; Brownell I;
Nat Rev Clin Oncol; 2018 Dec; 15(12):763-776. PubMed ID: 30287935
[TBL] [Abstract][Full Text] [Related]
12. In cancer cell lines inhibition of SCF/c-Kit pathway leads to radiosensitization only when SCF is strongly over-expressed.
Eberle F; Leinberger FH; Saulich MF; Seeger W; Engenhart-Cabillic R; Hänze J; Hattar K; Dikomey E; Subtil FSB
Clin Transl Radiat Oncol; 2017 Feb; 2():69-75. PubMed ID: 29658004
[TBL] [Abstract][Full Text] [Related]
13. Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment.
Müller-Richter UDA; Gesierich A; Kübler AC; Hartmann S; Brands RC
Ann Surg Oncol; 2017 Oct; 24(11):3430-3437. PubMed ID: 28762116
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options.
Saini AT; Miles BA
Onco Targets Ther; 2015; 8():2157-67. PubMed ID: 26316785
[TBL] [Abstract][Full Text] [Related]
15. Ligand-Mediated cis-Inhibition of Receptor Signaling in the Self-Incompatibility Response of the Brassicaceae.
Tantikanjana T; Nasrallah JB
Plant Physiol; 2015 Oct; 169(2):1141-54. PubMed ID: 26269543
[TBL] [Abstract][Full Text] [Related]
16. KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon Cancers.
Chen EC; Karl TA; Kalisky T; Gupta SK; O'Brien CA; Longacre TA; van de Rijn M; Quake SR; Clarke MF; Rothenberg ME
Gastroenterology; 2015 Sep; 149(3):705-17.e2. PubMed ID: 26026391
[TBL] [Abstract][Full Text] [Related]
17. BET protein inhibitor JQ1 attenuates Myc-amplified MCC tumor growth in vivo.
Shao Q; Kannan A; Lin Z; Stack BC; Suen JY; Gao L
Cancer Res; 2014 Dec; 74(23):7090-102. PubMed ID: 25277525
[TBL] [Abstract][Full Text] [Related]
18. Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response.
Iurlo A; Gianelli U; Beghini A; Spinelli O; Orofino N; Lazzaroni F; Cambiaghi S; Intermesoli T; Rambaldi A; Cortelezzi A
Oncotarget; 2014 Jul; 5(13):4665-70. PubMed ID: 25015329
[TBL] [Abstract][Full Text] [Related]
19. Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon?
Rabinowits G
Cancers (Basel); 2014 May; 6(2):1180-94. PubMed ID: 24840048
[TBL] [Abstract][Full Text] [Related]
20. Gene expression differences predict treatment outcome of merkel cell carcinoma patients.
Masterson L; Thibodeau BJ; Fortier LE; Geddes TJ; Pruetz BL; Malhotra R; Keidan R; Wilson GD
J Skin Cancer; 2014; 2014():596459. PubMed ID: 24634783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
